Engineering CAR T Cells for Hepatocellular Carcinoma Recurrence after Liver Transplantation
Lorenz Kocheise, Gabriel Prata Bacil, Pavan Bhimalli, Mohamed-Reda Benmebarek, D J Li, Patrick Huang, Chi Ma, Vinona Muralidaran, Jorge Humberto Hernández-Félix, Joseph R. Bugliarelli, Raj Chari, Kylynda C. Bauer, Yuta Myojin, Sarah Firdaus, Xiao Bin Zhu, , Tim F. Greten
This paper develops GPC3-targeted CAR T cells resistant to immunosuppressive drugs and with reduced alloreactivity, showing efficacy in preclinical models and feasibility for clinical use post-liver transplantation.
bioRxiv · Jul 5, 2026 · PreprintImmunology